Business Description
4basebio PLC
ISIN : GB00BMCLYF79
Share Class Description:
XTER:88Q: Ordinary SharesDescription
4basebio PLC is a life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for the effective and safe delivery of these DNA-based products to patients. Its country of operation is the UK. It is engaged in the manufacturing and supply of high-purity, synthetic DNA for research, therapeutic and pharmacological use.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.06 | |||||
| Equity-to-Asset | 0.3 | |||||
| Debt-to-Equity | 0.98 | |||||
| Debt-to-EBITDA | -0.53 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 13.73 | |||||
| Beneish M-Score | -2.57 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 11.2 | |||||
| 3-Year EBITDA Growth Rate | -215.3 | |||||
| 3-Year EPS without NRI Growth Rate | -131.2 | |||||
| 3-Year FCF Growth Rate | -142.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 81.43 | |||||
| 9-Day RSI | 77.74 | |||||
| 14-Day RSI | 76.05 | |||||
| 6-1 Month Momentum % | 75.38 | |||||
| 12-1 Month Momentum % | 55.1 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.42 | |||||
| Quick Ratio | 3.28 | |||||
| Cash Ratio | 2.4 | |||||
| Days Inventory | 846.38 | |||||
| Days Sales Outstanding | 68.39 | |||||
| Days Payable | 2965.85 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -1.22 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 80.51 | |||||
| Operating Margin % | -1946.33 | |||||
| Net Margin % | -1772.6 | |||||
| FCF Margin % | -1844.88 | |||||
| ROE % | -94.03 | |||||
| ROA % | -52.83 | |||||
| ROIC % | -88.38 | |||||
| ROC (Joel Greenblatt) % | -177 | |||||
| ROCE % | -66.65 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 364.29 | |||||
| PB Ratio | 36.82 | |||||
| Price-to-Tangible-Book | 120 | |||||
| EV-to-EBIT | -19.04 | |||||
| EV-to-Forward-EBIT | -10.32 | |||||
| EV-to-EBITDA | -20.6 | |||||
| EV-to-Forward-EBITDA | -11.37 | |||||
| EV-to-Revenue | 370.56 | |||||
| EV-to-Forward-Revenue | 39.23 | |||||
| EV-to-FCF | -19.85 | |||||
| Earnings Yield (Greenblatt) % | -5.26 | |||||
| FCF Yield % | -4.94 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
4basebio PLC Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.41 | ||
| EPS (TTM) (€) | -0.591 | ||
| Beta | 0 | ||
| Volatility % | 39.68 | ||
| 14-Day RSI | 76.05 | ||
| 14-Day ATR (€) | 0.259919 | ||
| 20-Day SMA (€) | 11.26 | ||
| 12-1 Month Momentum % | 55.1 | ||
| 52-Week Range (€) | 5.65 - 12.2 | ||
| Shares Outstanding (Mil) | 12.81 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
4basebio PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
4basebio PLC Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
4basebio PLC Frequently Asked Questions
What is 4basebio PLC(XTER:88Q)'s stock price today?
The current price of XTER:88Q is €12.00. The 52 week high of XTER:88Q is €12.20 and 52 week low is €5.65.
When is next earnings date of 4basebio PLC(XTER:88Q)?
The next earnings date of 4basebio PLC(XTER:88Q) is 2024-05-10 Est..
Does 4basebio PLC(XTER:88Q) pay dividends? If so, how much?
4basebio PLC(XTER:88Q) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers